scholarly journals Therapeutic Challenges to End-Stage Kidney Disease in a Patient with Tetralogy of Fallot

2015 ◽  
Vol 8 ◽  
pp. CCRep.S32121 ◽  
Author(s):  
Ken Ohara ◽  
Tetsu Akimoto ◽  
Takuya Miki ◽  
Naoko Otani ◽  
Taro Sugase ◽  
...  
Keyword(s):  
Kidney Disease ◽  
Tetralogy Of Fallot ◽  
Clinical Course ◽  
Disease Patient ◽  
End Stage Kidney Disease ◽  
Appetite Loss ◽  
Dialysis Treatment ◽  
Complex Processes ◽  
End Stage ◽  
Available Information

In this report, we describe the case of an end-stage kidney disease patient with tetralogy of Fallot (TOF). A 33-year-old female with TOF was admitted to our hospital with complaints of general fatigue and appetite loss probably due to uremic milieu. She was ultimately treated with peritoneal dialysis (PD) with a favorable clinical course. TOF patients with chronic kidney disease are not exceptional, although the currently available information regarding the association between TOF and renal failure severe enough to require dialysis treatment is limited. We also discuss the complex processes of how and why PD was selected as a mode of chronic renal replacement therapy in this case.

scholarly journals Accelerated extensive mitral valve calcification in a young end-stage kidney disease patient

2020 ◽  
Vol 41 (45) ◽  
pp. 4361-4361
Author(s):  
Saarwaani Vallabhajosyula ◽  
Sameh M Said ◽  
Anna S Kitzmann ◽  
Hector I Michelena
Keyword(s):  
Mitral Valve ◽  
Kidney Disease ◽  
Disease Patient ◽  
End Stage Kidney Disease ◽  
Valve Calcification ◽  
End Stage ◽  
Mitral Valve Calcification

scholarly journals Importance of AST-120 (Kremezin®) Adherence in a Chronic Kidney Disease Patient with Diabetes

2018 ◽  
Vol 8 (2) ◽  
pp. 107-111 ◽  
Author(s):  
Yasuhiko Tomino ◽  
Atsuko Hisada-Urita ◽  
Takuto Seki ◽  
Tomonari Watanabe ◽  
Reo Kanda ◽  
...  
Keyword(s):  
Chronic Kidney Disease ◽  
Kidney Disease ◽  
Serum Creatinine ◽  
Kidney Function ◽  
Japanese Society ◽  
Disease Patient ◽  
Insulin Injection ◽  
Adult Case ◽  
End Stage Kidney Disease ◽  
End Stage

We report herein an adult case of chronic kidney disease (CKD) associated with diabetes. The patient had been treated with insulin injection for diabetes 10 years ago. At the time of his first visit to our division for further examinations, we diagnosed him as CKD: cause (C) diabetes; glomerular filtration rate (GFR) (G) G5 (estimated [e] GFR, 10.2 mL/min/1.73 m2; serum creatinine of 4.90 mg/dL); and albuminuria (A) A3 (2.62 g/gCr) by the Japanese Society of Nephrology (JSN) CGA classification. Because he had complained of severe constipation and kidney function, i.e., eGFR was not improved by previous medications, we added on a minimal dosage (2 g/day) of AST-120 (Kremezin®; ordinary dose 6 g/day). After 3 months of AST-120 therapy, eGFR was increased to 17.8 mL/min/1.73 m2 (serum creatinine of 2.90–2.72 mg/dL). Although the patient used some laxative products, he could not continue to take Kremezin and completely stopped 8 months after starting this drug. Kidney function then abruptly declined and progressed to end-stage kidney disease (ESKD). In June 2017, he was introduced to hemodialysis. It appears that the adherence of Kremezin is very important for inhibiting the progression to ESKD for patients with CKD with diabetes.

scholarly journals Right Arm Pain and Swelling in an End-Stage Kidney Disease Patient

Kidney360 ◽  
2020 ◽  
Vol 1 (7) ◽  
pp. 714-715
Author(s):  
Sara S. Jdiaa ◽  
Diala I. Gebrael ◽  
Sahar H. Koubar
Keyword(s):  
Kidney Disease ◽  
Disease Patient ◽  
End Stage Kidney Disease ◽  
Arm Pain ◽  
End Stage

scholarly journals Discontinuing Hemodialysis with Patient Care and a Successful 9-Year Follow-up in a Patient Presumed to have End-Stage Kidney Disease Scheduled to Lifelong Hemodialysis: A Case Report

2021 ◽  
Vol 11 (1) ◽  
pp. 131-142
Author(s):  
Omer Toprak ◽  
Emel Aslan Bozyel ◽  
Burak Alp
Keyword(s):  
Kidney Disease ◽  
Patient Care ◽  
Disease Patient ◽  
Care Program ◽  
Lifestyle Changes ◽  
End Stage Kidney Disease ◽  
Patient Education Program ◽  
End Stage

End-stage kidney disease patients who require hemodialysis for more than 3 months have a small chance of leaving dialysis unless they have a kidney transplant. Educating the patient about lifestyle changes can play a major role in improving kidney function. Therefore, we created a patient education program according to our nephrology experiences. Herein, we show an end-stage kidney disease patient who underwent hemodialysis for 6 months. Afterwards, dialysis was terminated with patient care, and the patient was then followed up for 9 years without dialysis. To date, there have been no reports regarding the termination of long-term dialysis with a kidney care program and the ensuing 9-year follow-up without renal replacement therapy.

Sign in / Sign up

Export Citation Format

Share Document